Table 1.
Image-defined risk factors (IDRFs) in neuroblastic tumors
Ipsilateral tumour extension within two body compartments |
---|
Neck
|
Tumour encasing carotid and/or vertebral artery and/or internal jugular vein |
Tumour extending to base of the skull |
Tumour compressing the trachea |
Cervico-thoracic junction |
Tumour encasing brachial plexus roots |
Tumour encasing subclavian vessels and/or vertebral and/or carotid artery |
Tumour compressing the trachea |
Thorax |
Tumour encasing the aorta and/or major branches |
Tumour compressing the trachea and/or principal bronchi |
Lower mediastinal tumour, infiltrating the costo-vertebral junction between T9 and T12 |
Thoraco-abdominal |
Tumour encasing the aorta and/or the vena cava |
Abdomen/pelvis |
Tumour infiltrating the porta hepatis and/or the hepatoduodenal ligament |
Tumour encasing branches of the superior mesenteric artery and the mesenteric root |
Tumour encasing the origin of celiac axis and/or of the superior mesenteric artery |
Tumour invading one or both renal pedicles |
Tumour encasing the aorta and/or the vena cava |
Tumour encasing the iliac vessels |
Pelvic tumour across the sciatic notch |
Intraspinal tumour |
Extension, regardless of location, provided that more than one-third of the spinal canal in the axial plane is invaded and/or the perimedullary leptomeningeal spaces are not visible and/or the spinal cord signal is abnormal |
Infiltration of adjacent organs/structures |
Pericardium, diaphragm, kidney, liver, duodeno-pancreatic block and mesentery |
Conditions to be recorded, but not considered as IDRFs |
Multifocal primary tumours |
Pleural effusion, with or without malignant cells |
Ascites, with or without malignant cells |